Âé¶¹¹û¶³´«Ã½

Pulmonary Vascular Disease Program Research and Innovation

is a research leader in pulmonary vascular disease in both children and adults. There are few places in the world like , where research is so deeply supported and commonplace. We conduct a wide variety of research efforts for pulmonary vascular disease, which include clinical studies for monitoring outcomes in children with pulmonary hypertension, (bringing research discoveries into bedside clinical care), and bioengineering research. Learn more about our .

At , we have multiple, ongoing clinical trials for pulmonary hypertension. Ask your Stanford Children’s Health cardiology team or community cardiologist for a referral if you are interested in learning about innovative clinical treatments for your child.

In addition, our Âé¶¹¹û¶³´«Ã½ Children’s Health and Betty Irene Moore Children’s Heart Center providers are nationally recognized experts in the field and participate in multiple national and international organizations, focusing on advancing the care of children with pulmonary vascular disease, including the , the , and the .